BSE - Delayed Quote INR
Aurobindo Pharma Limited (AUROPHARMA.BO)
1,217.85
-39.75
(-3.16%)
At close: April 25 at 3:29:42 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
--
24,345,200
23,867,500
50,164,800
33,290,500
Investing Cash Flow
--
-42,559,500
-39,777,500
-32,115,600
5,986,900
Financing Cash Flow
--
8,004,200
18,144,100
-29,692,700
-13,649,400
End Cash Position
--
33,854,300
43,922,700
41,625,100
53,299,100
Capital Expenditure
--
-35,615,000
-27,204,000
-27,046,400
-18,738,100
Issuance of Debt
--
15,632,400
3,935,800
827,300
1,769,800
Repayment of Debt
--
-171,700
-56,500
--
-11,359,400
Free Cash Flow
--
-11,269,800
-3,336,500
23,118,400
14,552,400
3/31/2021 - 1/3/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
APLLTD.BO Alembic Pharmaceuticals Limited
875.45
-0.68%
SHILPAMED.BO Shilpa Medicare Limited
682.55
-5.52%
ZYDUSLIFE.BO Zydus Lifesciences Limited
859.10
-2.36%
ALKEM.BO Alkem Laboratories Limited
5,035.75
-3.52%
NATCOPHARM.BO NATCO Pharma Limited
889.65
-1.55%
SPARC.NS Sun Pharma Advanced Research Company Limited
149.77
-3.37%
DIVISLAB.BO Divi's Laboratories Limited
6,009.20
-3.32%
GRANULES.NS Granules India Limited
452.55
-4.74%
IPCALAB.NS Ipca Laboratories Limited
1,419.00
-1.85%
DRREDDY.BO Dr. Reddy's Laboratories Limited
1,173.55
-2.32%